Splenectomy during cytoreductive surgery in epithelial ovarian cancer

References

• KaramAKSantillanABristowRETertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcomeGynecol Oncol2007104237738017014899
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• IbeanuOABristowREPredicting the outcome of cytoreductive surgery for advanced ovarian cancer: a reviewInt J Gynecol Cancer201020Suppl 1S1S1120065732
   PubMedGoogle Scholar
• MarchettiCPisanoCFacchiniGFirst-line treatment of advanced ovarian cancer: current research and perspectivesExpert Rev Anticancer Ther2010101476020014885
   PubMed Web of Science ®Google Scholar
• ShihKKChiDSMaximal cytoreductive effort in epithelial ovarian cancer surgeryJ Gynecol Oncol2010212758020613895
   PubMed Web of Science ®Google Scholar
• MorganRJJrArmstrongDKAlvarezRDOvarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyJNCCN20161491134116327587625
   PubMedGoogle Scholar
• XiangLTuYHeTDistal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancerJ Gynecol Oncol2016276e6227550408
   PubMed Web of Science ®Google Scholar
• BacalbasaNBalescuIDimaSBrasoveanuVPopescuISplenectomy as part of cytoreductive surgery in recurrent epithelial ovarian cancerAnticancer Res20153595097510126254413
   PubMed Web of Science ®Google Scholar
• KohYSKimJCChoCKSplenectomy for solitary splenic metastasis of ovarian cancerBMC Cancer200449615615591
   PubMed Web of Science ®Google Scholar
• OtrockZKSeoudMAKhalifehMJMakaremJAShamseddineAILaparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancerInt J Gynecol Cancer20061651933193517009994
   PubMed Web of Science ®Google Scholar
• AlloniRGarberiniACaputoDCoppolaRSolitary splenic metastasis of ovarian carcinoma: report of two casesSurg Today200838121144114719039644
   PubMed Web of Science ®Google Scholar
• PetersAMWhy the spleen is a very rare site for metastases from epithelial cancersMed Hypotheses2012781262822088922
   PubMed Web of Science ®Google Scholar
• Pujade-LauraineEFujiwaraKDychterSSDevganGMonkBJAvelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study designFuture Oncol201814212103211329584456
   PubMed Web of Science ®Google Scholar
• RosePGPiverMSTsukadaYLauTSMetastatic patterns in histologic variants of ovarian cancer. An autopsy studyCancer1989647150815132776109
   PubMed Web of Science ®Google Scholar
• LvMLiYLuoCLiuPYangJSplenic metastasis of ovarian clear cell adenocarcinoma: a case report and review of the literatureExp Ther Med20147498298624669262
   PubMed Web of Science ®Google Scholar
• CompératEBardier-DupasACamparoPCapronFCharlotteFSplenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesisArch Pathol Lab Med2007131696596917550328
   PubMed Web of Science ®Google Scholar
• ManciNBellatiFMuziiLSplenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival dataAnn Surg Oncol200613121717172316957965
   PubMed Web of Science ®Google Scholar
• NicklinJCopelandLO’TooleRLewandowskiGVaccarelloLHavenarLSplenectomy as part of cytoreductive surgery for ovarian carcinomaInt J Gynaecol Obstet1996523333333
   Google Scholar
• BacalbasaNBalescuIDimaSBrasoveanuVPopescuIHematogenous splenic metastases as an independent negative prognosis factor at the moment of primary cytoreduction in advanced stage epithelial ovarian cancer: a single center experienceAnticancer Res201535105649565426408738
   PubMed Web of Science ®Google Scholar
• AyhanAAlRABaykalCDemirtasEAyhanAYüceKThe influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancerInt J Gynecol Cancer2004141515614764029
   PubMed Web of Science ®Google Scholar
• HanprasertpongJFujiwaraKSplenectomy and surgical cytoreduction in epithelial ovarian cancer: a reviewEur J Cancer Care2011203287293
   PubMed Web of Science ®Google Scholar
• MillerEMTymon-RosarioJXieXUtilization of intraperitoneal chemotherapy for optimally cytoreduced advanced stage epithelial ovarian cancer: a 10-year single institution experience with a racially diverse urban populationGynecol Oncol20171471364028751119
   PubMed Web of Science ®Google Scholar
• AlbertsDSLiuPYHanniganEVIntraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancerN Engl J Med199633526195019558960474
   PubMed Web of Science ®Google Scholar
• MarkmanMBundyBNAlbertsDSPhase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose car-boplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology GroupJ Clin Oncol20011941001100711181662
   PubMed Web of Science ®Google Scholar
• ArmstrongDKBundyBWenzelLIntraperitoneal cisplatin and paclitaxel in ovarian cancerN Engl J Med20063541344316394300
   PubMed Web of Science ®Google Scholar
• LeeJCurtinJPMuggiaFMPothuriBBoydLRBlankSVTiming is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancerCancer Chemother Pharmacol2018821556329704010
   PubMed Web of Science ®Google Scholar
• WrightJDHouJYBurkeWMUtilization and toxicity of alternative delivery methods of adjuvant chemotherapy for ovarian cancerObstet Gynecol2016127698599127159764
   PubMed Web of Science ®Google Scholar
• HavrileskyLJAlvarez SecordAEhrismanJAPatient preferences in advanced or recurrent ovarian cancerCancer2014120233651365925091693
   PubMed Web of Science ®Google Scholar
• FagottiAFerrandinaGFanfaniFProspective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinomaAm J Obstet Gynecol20081996e641-646642-642.e6
   Web of Science ®Google Scholar
• WeitzJJaquesDPBrennanMKarpehMAssociation of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancerAnn Surg Oncol200411768268915231523
   PubMed Web of Science ®Google Scholar
• ChuaTCYanTDSaxenaAMorrisDLShould the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortalityAnn Surg2009249690090719474692
   PubMed Web of Science ®Google Scholar
• EatonMAValentineJJacksonMRModrallGClagettPIncidental splenic injury during abdominal vascular surgery: a case-controlled analysisJ Am Coll Surg20001901586410625233
   PubMed Web of Science ®Google Scholar
• MettkeRSchmidtAWolffSSpleen injuries during colorectal carcinoma surgery. Effect on the early postoperative resultDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen201283980981422434365
   PubMed Web of Science ®Google Scholar
• BisharatNOmariHLaviIRazRRisk of infection and death among post-splenectomy patientsJ Infect200143318218611798256
   PubMed Web of Science ®Google Scholar
• DagbertFThievenazRDecullierESplenectomy increases postoperative complications following cytoreductive surgery and hyper-thermic intraperitoneal chemotherapyAnn Surg Oncol20162361980198526913716
   PubMed Web of Science ®Google Scholar
• MagtibayPMAdamsPBSilvermanMBChaSSPodratzKCSplenectomy as part of cytoreductive surgery in ovarian cancerGynecol Oncol2006102236937416631919
   PubMed Web of Science ®Google Scholar
• EisenkopSMSpirtosNMLinW-CMSplenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancerGynecol Oncol2006100234434816202446
   PubMed Web of Science ®Google Scholar
• CadiliAde GaraCComplications of splenectomyAm J Med2008121537137518456028
   PubMed Web of Science ®Google Scholar
• WaghornDJOverwhelming infection in asplenic patients: current best practice preventive measures are not being followedJ Clin Pathol200154321421811253134
   PubMed Web of Science ®Google Scholar
• BuzeléRBarbierLSauvanetAFantinBMedical complications following splenectomyJ Visc Surg2016153427728627289254
   PubMed Web of Science ®Google Scholar
• SpencerNJBSpencerJAPerrenTJLaneGCT appearances and prognostic significance of splenic metastasis in ovarian cancerClin Radiol19985364174219651056
   PubMed Web of Science ®Google Scholar
• PiuraEPiuraBSplenic metastases from female genital tract malignancies]Harefuah2010149531532020929072
   PubMedGoogle Scholar
• KugimiyaNSutoRKanedaYA case of solitary splenic metastasis from ovarian cancer resected by laparoscopic partial splenectomyJpn J Gastroenterol Surg2008412224228
   Google Scholar
• Marriqoun-HarrisFRhouYJJStoreyDPatherSProlonged survival after laparoscopic splenectomy for recurrent ovarian cancer and no adjuvant therapy: a report and review of the literatureS Afr J Gynaecol Oncol2013525861
   Google Scholar
• MccannCKGrowdonWBMunroEGPrognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancerAnn Surg Oncol201118102912291821424880
   PubMed Web of Science ®Google Scholar
• NicklinJLCopelandLJO’TooleRVLewandowskiGSVaccarelloLHavenarLPSplenectomy as part of cytoreductive surgery for ovarian carcinomaGynecol Oncol19955822442477622112
   PubMed Web of Science ®Google Scholar
• L-MayChenLeuchterRSLagasseLDKarlanBYSplenectomy and surgical cytoreduction for ovarian cancerGynecol Oncol200077336236810831343
   PubMed Web of Science ®Google Scholar
• ZapardielIPeirettiMZanagnoloVSplenectomy as part of primary cytoreductive surgery for advanced ovarian cancer: a retrospective cohort studyInt J Gynecol Cancer201222696897322672988
   PubMed Web of Science ®Google Scholar